Suppr超能文献

相似文献

1
Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation.
Blood. 2014 Jul 31;124(5):761-70. doi: 10.1182/blood-2014-01-551184. Epub 2014 Jun 23.
2
Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma.
Blood. 2016 Mar 10;127(10):1287-96. doi: 10.1182/blood-2015-08-662353. Epub 2016 Jan 5.
3
Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins.
Blood. 2007 Apr 15;109(8):3325-32. doi: 10.1182/blood-2006-04-017863. Epub 2006 Dec 19.
5
Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome.
Blood Cancer J. 2020 May 14;10(5):57. doi: 10.1038/s41408-020-0324-3.
6
Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma.
Toxins (Basel). 2013 Aug 14;5(8):1402-21. doi: 10.3390/toxins5081402.
7
Staphylococcus aureus Induces Signal Transducer and Activator of Transcription 5‒Dependent miR-155 Expression in Cutaneous T-Cell Lymphoma.
J Invest Dermatol. 2021 Oct;141(10):2449-2458. doi: 10.1016/j.jid.2021.01.038. Epub 2021 Apr 20.
8
Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome.
Blood. 2024 Apr 11;143(15):1496-1512. doi: 10.1182/blood.2023021671.
9
Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3/Stat3 signaling pathway.
J Invest Dermatol. 2011 Jun;131(6):1331-8. doi: 10.1038/jid.2011.27. Epub 2011 Feb 24.

引用本文的文献

1
Ionizing radiation improves skin bacterial dysbiosis in cutaneous T-cell lymphoma.
Front Immunol. 2024 Dec 24;15:1520214. doi: 10.3389/fimmu.2024.1520214. eCollection 2024.
2
Cutaneous T-Cell Lymphoma and Microbiota: Etiopathogenesis and Potential New Therapeutic Targets.
Dermatol Res Pract. 2024 Feb 22;2024:9919225. doi: 10.1155/2024/9919225. eCollection 2024.
3
Microbiome in Cancer Development and Treatment.
Microorganisms. 2023 Dec 22;12(1):24. doi: 10.3390/microorganisms12010024.
4
Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome.
Blood. 2024 Apr 11;143(15):1496-1512. doi: 10.1182/blood.2023021671.
5
Enterotoxins A and B produced by increase cell proliferation, invasion and cytarabine resistance in acute myeloid leukemia cell lines.
Heliyon. 2023 Sep 2;9(9):e19743. doi: 10.1016/j.heliyon.2023.e19743. eCollection 2023 Sep.
7
Bidirectional Functional Effects of on Carcinogenesis.
Microorganisms. 2022 Nov 28;10(12):2353. doi: 10.3390/microorganisms10122353.
8
Narrowband ultraviolet B response in cutaneous T-cell lymphoma is characterized by increased bacterial diversity and reduced and .
Front Immunol. 2022 Nov 11;13:1022093. doi: 10.3389/fimmu.2022.1022093. eCollection 2022.
9
The Skin Microbiome in Cutaneous T-Cell Lymphomas (CTCL)-A Narrative Review.
Pathogens. 2022 Aug 18;11(8):935. doi: 10.3390/pathogens11080935.
10
miRNA Signature in Early-stage Mycosis Fungoides.
Acta Derm Venereol. 2022 Oct 4;102:adv00785. doi: 10.2340/actadv.v102.628.

本文引用的文献

2
Lymphocytic infiltration in the cutaneous lymphoma microenvironment after injection of TG1042.
J Transl Med. 2013 Sep 25;11:226. doi: 10.1186/1479-5876-11-226.
3
The cytotoxic necrotizing factor 1 from E. coli: a janus toxin playing with cancer regulators.
Toxins (Basel). 2013 Aug 14;5(8):1462-74. doi: 10.3390/toxins5081462.
4
Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma.
Blood. 2013 Aug 8;122(6):943-50. doi: 10.1182/blood-2013-01-480889. Epub 2013 Jun 25.
5
TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma.
Clin Cancer Res. 2013 Jul 15;19(14):3755-63. doi: 10.1158/1078-0432.CCR-12-3488. Epub 2013 Jun 19.
6
Cytokine patterns in patients with cancer: a systematic review.
Lancet Oncol. 2013 May;14(6):e218-28. doi: 10.1016/S1470-2045(12)70582-X.
7
Intestinal inflammation targets cancer-inducing activity of the microbiota.
Science. 2012 Oct 5;338(6103):120-3. doi: 10.1126/science.1224820. Epub 2012 Aug 16.
8
Long-term outcomes of 1,263 patients with mycosis fungoides and Sézary syndrome from 1982 to 2009.
Clin Cancer Res. 2012 Sep 15;18(18):5051-60. doi: 10.1158/1078-0432.CCR-12-0604. Epub 2012 Jul 31.
9
Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy.
Immunol Res. 2011 Dec;51(2-3):170-82. doi: 10.1007/s12026-011-8262-6.
10
IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
Clin Cancer Res. 2011 Dec 15;17(24):7529-38. doi: 10.1158/1078-0432.CCR-11-1192. Epub 2011 Nov 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验